The impact of changing from ocrelizumab to ofatumumab on disease activity, infection and immunological parameters in patients with multiple sclerosis

被引：0
|
作者：
Montague, Turlough [1 ]
Chatterton, Sophie [1 ]
Cheung, Emily [1 ]
Thomas, Karen [1 ]
Simpson-Burke, Nicole [1 ]
Markoulis, Katherine [1 ]
Miller, Celia [1 ]
Fontes-Villalba, Ariadna [1 ]
Parratt, John [1 ]
机构：
[1] Royal North Shore Hosp, Sydney, NSW, Australia
来源：
MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1715/1624
引用
收藏
页码：1084 / 1084
页数：1
相关论文
共 50 条
  • [31] A single centre analysis of infection and immune parameters in patients undergoing treatment with Ocrelizumab for Multiple Sclerosis at the Queen Elizabeth Hospital in Birmingham (UK)
    Thompson, H.
    Kon, E.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 997 - 998
  • [32] Impact of Ramadan fasting on disease activity in patients with multiple sclerosis: a multicenter study
    Hassan, Amr
    Merghany, Nahla
    Ouchkat, Fatima
    Regragui, Wafa
    Kedah, Hanaa
    Hamdy, Sherif M.
    Abdel-Naseer, Maged
    Shehata, Hatem S.
    Shalaby, Nevin M.
    Kishk, Nirmeen A.
    Nada, Mona A. F.
    Hegazy, Mohamed, I
    Farghaly, Marwa
    Ahmed, Sandra M.
    Hussein, Mona
    NUTRITIONAL NEUROSCIENCE, 2022, 25 (12) : 2680 - 2689
  • [33] Effect of ofatumumab treatment on disability progression independent of relapse activity in patients with relapsing multiple sclerosis
    Kappos, L.
    Montalban, X.
    Cohen, J. A.
    Comi, G.
    Coyle, P. K.
    Li, B.
    Sfikas, N.
    Willi, R.
    Haring, D. A.
    Merschhemke, M.
    Hauser, S. L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 47 - 47
  • [34] Impact of chemerin, lipid profile, and insulin resistance on disease parameters in patients with multiple sclerosis
    Koskderelioglu, Asli
    Gedizlioglu, Muhtesem
    Eskut, Neslihan
    Tamer, Pinar
    Yalcin, Gizem
    Bozkaya, Giray
    NEUROLOGICAL SCIENCES, 2021, 42 (06) : 2471 - 2479
  • [35] Impact of chemerin, lipid profile, and insulin resistance on disease parameters in patients with multiple sclerosis
    Asli Koskderelioglu
    Muhtesem Gedizlioglu
    Neslihan Eskut
    Pinar Tamer
    Gizem Yalcin
    Giray Bozkaya
    Neurological Sciences, 2021, 42 : 2471 - 2479
  • [36] Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies
    Yeh, Wei Z.
    van der Walt, Anneke
    Skibina, Olga G.
    Kalincik, Tomas
    Alroughani, Raed
    Kermode, Allan G.
    Fabis-Pedrini, Marzena J.
    Carroll, William M.
    Lechner-Scott, Jeannette
    Boz, Cavit
    Ozakbas, Serkan
    Buzzard, Katherine
    Habek, Mario
    John, Nevin A.
    Prat, Alexandre
    Girard, Marc
    Duquette, Pierre
    Baghbanian, Seyed Mohammad
    Hodgkinson, Suzanne
    Van Pesch, Vincent
    Laureys, Guy
    Willekens, Barbara
    Prevost, Julie
    Foschi, Matteo
    De Gans, Koen
    Horakova, Dana
    Havrdova, Eva Kubala
    Karabudak, Rana
    Patti, Francesco
    Mccombe, Pamela A.
    Maimone, Davide
    Altintas, Ayse
    Ampapa, Radek
    Spitaleri, Daniele
    Gerlach, Oliver H. H.
    Sa, Maria Jose
    Hughes, Stella
    Gouider, Riadh
    Mrabet, Saloua
    Macdonell, Richard A.
    Turkoglu, Recai
    Cartechini, Elisabetta
    Al-Asmi, Abdullah
    Soysal, Aysun
    Oh, Jiwon
    Muros-Le Rouzic, Erwan
    Guye, Sabrina
    Pasquarelli, Noemi
    Butzkueven, Helmut
    Jokubaitis, Vilija G.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2024, 11 (06):
  • [37] No evidence of disease activity in multiple sclerosis patients
    da Cunha Matta, Andre Palma
    Nascimento, Osvaldo J. M.
    Ferreira, Ana Carolina Andorinho de F.
    Magalhaes, Thais Nascimento
    Resende Benevides, Tais Pais
    Kirmse, Arielle
    Dib, Joao Gabriel
    Cal, Henrique
    Orsini, Marco
    Araujo, Lucas Masiero
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (11) : 1279 - 1284
  • [38] Immunological patterns identifying disease course and disease evolution in multiple sclerosis patients
    Furlan, R
    Rovaris, M
    Boneschi, FM
    Khademi, M
    Bergami, A
    Gironi, M
    Deleidi, M
    Agosta, F
    Franciotta, D
    Scarpini, E
    Uccelli, A
    Zaffaroni, M
    Kurne, A
    Comi, G
    Olsson, T
    Filippi, M
    Martino, G
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 154 (1-2) : 101 - 101
  • [39] Ofatumumab and Early Immunological Cells Subset Characterization in Naive Relapsing Multiple Sclerosis Patients: A Real-World Study
    D'Amico, Emanuele
    Zanghi, Aurora
    Fantozzi, Roberta
    Centonze, Diego
    Avolio, Carlo
    CURRENT NEUROPHARMACOLOGY, 2023, 21 (12) : 2563 - 2566
  • [40] Impact of Age on Multiple Sclerosis Disease Activity and Progression
    Burcu Zeydan
    Orhun H. Kantarci
    Current Neurology and Neuroscience Reports, 2020, 20
12345